372 related articles for article (PubMed ID: 18558642)
1. Olanzapine in the treatment of low body weight and obsessive thinking in women with anorexia nervosa: a randomized, double-blind, placebo-controlled trial.
Bissada H; Tasca GA; Barber AM; Bradwejn J
Am J Psychiatry; 2008 Oct; 165(10):1281-8. PubMed ID: 18558642
[TBL] [Abstract][Full Text] [Related]
2. The perplexities of conducting randomized, double-blind, placebo-controlled treatment trials in anorexia nervosa patients.
Halmi KA
Am J Psychiatry; 2008 Oct; 165(10):1227-8. PubMed ID: 18829874
[No Abstract] [Full Text] [Related]
3. Evaluation of the efficacy and safety of olanzapine as an adjunctive treatment for anorexia nervosa in adolescent females: a randomized, double-blind, placebo-controlled trial.
Spettigue W; Buchholz A; Henderson K; Feder S; Moher D; Kourad K; Gaboury I; Norris M; Ledoux S
BMC Pediatr; 2008 Jan; 8():4. PubMed ID: 18234120
[TBL] [Abstract][Full Text] [Related]
4. A placebo-controlled pilot study of adjunctive olanzapine for adolescents with anorexia nervosa.
Kafantaris V; Leigh E; Hertz S; Berest A; Schebendach J; Sterling WM; Saito E; Sunday S; Higdon C; Golden NH; Malhotra AK
J Child Adolesc Psychopharmacol; 2011 Jun; 21(3):207-12. PubMed ID: 21663423
[TBL] [Abstract][Full Text] [Related]
5. Olanzapine Versus Placebo in Adult Outpatients With Anorexia Nervosa: A Randomized Clinical Trial.
Attia E; Steinglass JE; Walsh BT; Wang Y; Wu P; Schreyer C; Wildes J; Yilmaz Z; Guarda AS; Kaplan AS; Marcus MD
Am J Psychiatry; 2019 Jun; 176(6):449-456. PubMed ID: 30654643
[TBL] [Abstract][Full Text] [Related]
6. An open trial of olanzapine in anorexia nervosa.
Barbarich NC; McConaha CW; Gaskill J; La Via M; Frank GK; Achenbach S; Plotnicov KH; Kaye WH
J Clin Psychiatry; 2004 Nov; 65(11):1480-2. PubMed ID: 15554759
[TBL] [Abstract][Full Text] [Related]
7. Metformin addition attenuates olanzapine-induced weight gain in drug-naive first-episode schizophrenia patients: a double-blind, placebo-controlled study.
Wu RR; Zhao JP; Guo XF; He YQ; Fang MS; Guo WB; Chen JD; Li LH
Am J Psychiatry; 2008 Mar; 165(3):352-8. PubMed ID: 18245179
[TBL] [Abstract][Full Text] [Related]
8. Does fluoxetine augment the inpatient treatment of anorexia nervosa?
Attia E; Haiman C; Walsh BT; Flater SR
Am J Psychiatry; 1998 Apr; 155(4):548-51. PubMed ID: 9546003
[TBL] [Abstract][Full Text] [Related]
9. The role of olanzapine in the treatment of anorexia nervosa.
Dunican KC; DelDotto D
Ann Pharmacother; 2007 Jan; 41(1):111-5. PubMed ID: 17190846
[TBL] [Abstract][Full Text] [Related]
10. Olanzapine therapy in anorexia nervosa: psychobiological effects.
Brambilla F; Garcia CS; Fassino S; Daga GA; Favaro A; Santonastaso P; Ramaciotti C; Bondi E; Mellado C; Borriello R; Monteleone P
Int Clin Psychopharmacol; 2007 Jul; 22(4):197-204. PubMed ID: 17519642
[TBL] [Abstract][Full Text] [Related]
11. Olanzapine versus placebo for out-patients with anorexia nervosa.
Attia E; Kaplan AS; Walsh BT; Gershkovich M; Yilmaz Z; Musante D; Wang Y
Psychol Med; 2011 Oct; 41(10):2177-82. PubMed ID: 21426603
[TBL] [Abstract][Full Text] [Related]
12. [Olanzapine in the treatment of adolescents with anorexia nervosa].
Hein IM; Huyser C
Tijdschr Psychiatr; 2010; 52(6):417-21. PubMed ID: 20544600
[TBL] [Abstract][Full Text] [Related]
13. A double-blind, placebo-controlled study of risperidone for the treatment of adolescents and young adults with anorexia nervosa: a pilot study.
Hagman J; Gralla J; Sigel E; Ellert S; Dodge M; Gardner R; O'Lonergan T; Frank G; Wamboldt MZ
J Am Acad Child Adolesc Psychiatry; 2011 Sep; 50(9):915-24. PubMed ID: 21871373
[TBL] [Abstract][Full Text] [Related]
14. Successful olanzapine treatment of anorexia nervosa in a girl with pervasive developmental disorder not otherwise specified.
Tateno M; Teshirogi H; Kamasaki H; Saito T
Psychiatry Clin Neurosci; 2008 Dec; 62(6):752. PubMed ID: 19068020
[No Abstract] [Full Text] [Related]
15. Use of olanzapine in anorexia nervosa.
Menaster M
J Clin Psychiatry; 2005 May; 66(5):654-5; author reply 655-6. PubMed ID: 15889956
[No Abstract] [Full Text] [Related]
16. Olanzapine treatment in anorexia nervosa: case report.
Dadić-Hero E; Ruzić K; Pernar M; Kabalin M; Medved P
Psychiatr Danub; 2009 Mar; 21(1):122-5. PubMed ID: 19270636
[TBL] [Abstract][Full Text] [Related]
17. Olanzapine use for the adjunctive treatment of adolescents with anorexia nervosa.
Norris ML; Spettigue W; Buchholz A; Henderson KA; Gomez R; Maras D; Gaboury I; Ni A
J Child Adolesc Psychopharmacol; 2011 Jun; 21(3):213-20. PubMed ID: 21510781
[TBL] [Abstract][Full Text] [Related]
18. A double-blind, placebo-controlled trial of sibutramine for olanzapine-associated weight gain.
Henderson DC; Copeland PM; Daley TB; Borba CP; Cather C; Nguyen DD; Louie PM; Evins AE; Freudenreich O; Hayden D; Goff DC
Am J Psychiatry; 2005 May; 162(5):954-62. PubMed ID: 15863798
[TBL] [Abstract][Full Text] [Related]
19. Are antipsychotics effective for the treatment of anorexia nervosa? Results from a systematic review and meta-analysis.
Kishi T; Kafantaris V; Sunday S; Sheridan EM; Correll CU
J Clin Psychiatry; 2012 Jun; 73(6):e757-66. PubMed ID: 22795216
[TBL] [Abstract][Full Text] [Related]
20. A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study.
McQuade RD; Stock E; Marcus R; Jody D; Gharbia NA; Vanveggel S; Archibald D; Carson WH
J Clin Psychiatry; 2004; 65 Suppl 18():47-56. PubMed ID: 15600384
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
